FU-tet-o-hKLF4 Citations (4)
Originally described in: A high-efficiency system for the generation and study of human induced pluripotent stem cells.Maherali N, Ahfeldt T, Rigamonti A, Utikal J, Cowan C, Hochedlinger K Cell Stem Cell. 2008 Sep 11. 3(3):340-5. PubMed Journal
Articles Citing FU-tet-o-hKLF4
Articles |
---|
PAX5 is the transcriptional activator of mucolipin-2 (MCOLN2) gene. Valadez JA, Cuajungco MP. Gene. 2015 Jan 25;555(2):194-202. doi: 10.1016/j.gene.2014.11.003. Epub 2014 Nov 6. PubMed |
KLF4 N-terminal variance modulates induced reprogramming to pluripotency.
Kim SI, Oceguera-Yanez F, Hirohata R, Linker S, Okita K, Yamada Y, Yamamoto T, Yamanaka S, Woltjen K.
Stem Cell Reports. 2015 Apr 14;4(4):727-43. doi: 10.1016/j.stemcr.2015.02.004. Epub 2015 Mar 12.
PubMed
Associated Plasmids |
p63 establishes epithelial enhancers at critical craniofacial development genes. Lin-Shiao E, Lan Y, Welzenbach J, Alexander KA, Zhang Z, Knapp M, Mangold E, Sammons M, Ludwig KU, Berger SL. Sci Adv. 2019 May 1;5(5):eaaw0946. doi: 10.1126/sciadv.aaw0946. eCollection 2019 May. PubMed |
Disease-related p63 DBD mutations impair DNA binding by distinct mechanisms and varying degree. Osterburg C, Ferniani M, Antonini D, Frombach AS, D'Auria L, Osterburg S, Lotz R, Lohr F, Kehrloesser S, Zhou H, Missero C, Dotsch V. Cell Death Dis. 2023 Apr 18;14(4):274. doi: 10.1038/s41419-023-05796-y. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.